Cancer immunotherapy treatments harness the power of a patient’s own immune system to recognize and destroy cancer cells.
SITC Cancer Immunotherapy CONNECT is your hub to learn about cancer immunotherapy and its potential for the future. Download a variety of resources in our library and connect to other patients and healthcare professionals in our online community to learn more about this powerful new treatment option for cancer.
The use of this treatment dates back to the late 1800s; however, the science has never before experienced such positive momentum in improving the lives of patients with cancer as in recent years. As more immunotherapy treatments receive U.S. Food and Drug Administration (FDA) approval for a variety of cancer types, stay connected with SITC for up-to-date resources and education about immunotherapy for cancer treatment.
Submission Period Closes: Tuesday, February 20, 2018 at 5 p.m. EST
*Must be a SITC member to apply.
The majority of NSCLC patients do not still respond to PD-1/PD-L1 treatment. Chemotherapy is theorized to increase the release of tumor antigen resulting in increased response with immunotherapy. ...
more details in our latest news story: bit.ly/2CpnCWQ ------------------------------ Jade Parker Editor Future Science Group ------------------------------
Course Name: 6 th Annual Lung Cancer Symposium
Course Date: Friday, March 2, 2018
Course Co-Directors and Planners : Ralph Zinner, MD; Gregory Kane, MD; Judith Alberto, RPh; Rita ...
This message was posted by a user wishing to remain anonymous Hi All His is an attempt to find answers on the observed onset of effect on Opdivo / Nivolumab treatment. If you are a doctor ...
View More Patient Resources
Launched in July of 2016, SITC presents the newest in a series of videos focusing on immunotherapy for NSCLC patients, the NSCLC Immunotherapy: Advancing HopeTM video provides an overview of the building blocks of the immune system and immunotherapy, while also highlighting some* of the available FDA approved immunotherapy treatments and potential side effects, and the importance of clinical trials.
For more than 30 years SITC (Society for Immunotherapy of Cancer) has been fighting for treatment and a cure for cancer through research and collaboration. SITC members all over the world are leading the charge against cancer. We’re traveling the globe to meet these thought leaders and demonstrate the crucial work that they’re doing to impact advances in both the science and clinical application of immunotherapy.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: firstname.lastname@example.org